That COVID-19 rapid test detect antibodies developed so you have to had contracted COVID-19 in the first place and recover from it. If there is a cough signature for coronavirus such as SARS, COVID-19, etc, that's where this will benefit RAP's biomarket technology but I agree, it shouldn't be the priority of RAP right now.
RAP Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held